The Science of Mesotherapy

What is the defining principle of mesotherapy as originally introduced by Dr. Michel Pistor?

Which statement best explains why mesotherapy is considered more effective than topical skincare for certain indications?

Which group of components is specifically described as supporting fibroblast activity and extracellular matrix production in mesotherapy solutions?

Why must only products approved for microneedling be used during mesotherapy with this technique?

What is the primary clinical rationale for using non-crosslinked hyaluronic acid in mesotherapy rather than crosslinked hyaluronic acid?

When treating epidermal pigmentation with microneedling, which depth and tissue response are considered correct?

Which mechanism explains the role of tranexamic acid in depigmenting mesotherapy formulations?

Why is rosacea treated at shallower depths than aging skin, despite targeting vascular and structural changes?

Which pairing of indication and dermal target is correctly matched according to the lecture?

What is the main clinical trade-off between the papule technique and the nappage technique in injectable mesotherapy?